TO PROVIDE GRANTS TO SECTION 501C3 ORGANIZATIONS THAT ADVANCE AND IMPROVE SCIENTIFIC RESEARCH IN IMMUNOTHERAPY AND TO ORGANIZATIONS THAT PROMOTE, ADVANCE AND IMPROVE EDUCATION AND SUPPORT CANCER PATIENTS
Reported officers (all unpaid)
No paid executives reported in 2024. The National Immunotherapy Cancer reported 4 unpaid officers and board members on its 990.
Revenue and expenses over time
The National Immunotherapy Cancer reported revenue and expenses across 2 filing years.
What Medical Research executives earn
The National Immunotherapy Cancer reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization nationwide earns a median of $120,264.
These are medical research sector-wide figures, not this organization's reported pay. Based on 1,118 organizations across 1,118 filings (2020 – 2024).
See full Medical Research compensation data →Common questions about The National Immunotherapy Cancer
What are The National Immunotherapy Cancer's revenue and expenses?
In 2024, The National Immunotherapy Cancer reported $390k in total revenue and $100k in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.